503
Participants
Start Date
October 19, 2009
Primary Completion Date
May 1, 2011
Study Completion Date
May 12, 2011
Fluticasone Furoate/GW642444
Combination inhaled corticosteroid and long-acting beta2-agonist
Fluticasone propionate
Inhaled corticosteroid
GSK Investigational Site, Bangkok
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Bangkok
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Potsdam
GSK Investigational Site, Bethesda
GSK Investigational Site, Reinfeld
GSK Investigational Site, Raleigh
GSK Investigational Site, Oxford
GSK Investigational Site, Khon Kaen
GSK Investigational Site, Cincinnati
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Chiang Mai
GSK Investigational Site, Greenfield
GSK Investigational Site, Offenbach
GSK Investigational Site, Mannheim
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Dallas
GSK Investigational Site, Waco
GSK Investigational Site, San Antonio
GSK Investigational Site, Austin
GSK Investigational Site, El Paso
GSK Investigational Site, Donetsk
GSK Investigational Site, Donetsk
GSK Investigational Site, Bad Woerrishofen
GSK Investigational Site, Rolling Hills Estates
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Mission Viejo
GSK Investigational Site, Simferopol
GSK Investigational Site, Stockton
GSK Investigational Site, Bellevue
GSK Investigational Site, Skillman
GSK Investigational Site, South Burlington
GSK Investigational Site, Dresden
GSK Investigational Site, Leipzig
GSK Investigational Site, Leipzig
GSK Investigational Site, Radebeul
GSK Investigational Site, Schmölln
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
Lead Sponsor
GlaxoSmithKline
INDUSTRY